Shanghai MicroPort Stock Hits Day High with 3.93% Surge

Shanghai MicroPort Endovascular MedTech Co., Ltd. has experienced a notable increase of 3.93% on June 2, 2026, reaching an intraday high of CNY 104.82. This performance stands in contrast to the China Shanghai Composite, which only gained 0.43% on the same day. Over the past week, the stock has shown a 2.3% increase, while the broader index has declined by 1.7%. In terms of longer-term performance, Shanghai MicroPort has achieved an 18.77% return over the past year, although this is slightly below the China Shanghai Composite's 21.74%. Year-to-date, the stock has risen by 13.95%, significantly outperforming the index's 2.68% gain. However, the three-year and five-year performance metrics reveal a decline of 35.48% and 73.7%, respectively, indicating a challenging period for the company. With a market capitalization of CNY 12,779 million, Shanghai MicroPort operates within the Pharmaceuticals & Biotechnology sector. The company currently holds a Price to Book ratio of 3.03 and a return on equity of 13.73%, reflecting its financial positioning in the market.